CC BY 4.0 · Eur J Dent 2024; 18(04): 1062-1068
DOI: 10.1055/s-0044-1779425
Original Article

Potency of Hyperbaric Oxygen Therapy on Oral Candidiasis Diabetes Mellitus

1   Department of Oral Biology, Faculty of Dentistry, Universitas Hang Tuah, Surabaya, Indonesia
,
1   Department of Oral Biology, Faculty of Dentistry, Universitas Hang Tuah, Surabaya, Indonesia
,
2   Department of Oral Medicine, Faculty of Dentistry, Universitas Hang Tuah, Surabaya, Indonesia
› Author Affiliations
Funding This research was supported by Internal Research Program Grant, funded by Universitas Hang Tuah Academic Year 2022/2023.

Abstract

Objectives This study aimed to determine the potency of hyperbaric oxygen therapy (HBOT) to the blood glucose level, amount of lymphocytes, and the expression of antibody anti-Candida in oral candidiasis diabetes mellitus.

Materials and Methods Thirty Wistar rats were divided into five groups: K1 normal-control group, while K2, P1, P2, and P3 were diabetes induced by streptozotocin 50 mg/kg body weight. Oral candidiasis was induced by inoculation 0.1 mL Candida albicans ATCC 10321 on dorsum of the tongue. P1 was given nystatin oral suspension, P2 was treated by HBOT 2.4 ATA, 3 × 30 minutes each with a 5-minute interval, and P3 was treated by the combination of nystatin and HBOT. All the treatments were performed for 5 consecutive days. Fasting blood glucose level was examined on glucometer strips, lymphocyte was examined from complete blood count, and the expression of antibody anti-Candida was examined on immunohistochemistry staining

Statistical Analysis Data analyzed by a one-way analysis of variance and least significant difference test with the result of p-value less than 0.05 was considered to be statistically significant.

Results HBOT reduced blood glucose level (p > 0.05) increased the amount of lymphocyte (p < 0.05). All treatments reduced the expression of antibody anti-Candida (p < 0.05) with the best result on combination of HBOT with nystatin.

Conclusion HBOT decreased the blood glucose level, increased the amount of lymphocytes, and reduced the expression of antibody anti-Candida in oral candidiasis diabetes mellitus.



Publication History

Article published online:
31 March 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 2023; 402 (10397): 203-234
  • 2 Nazir MA, AlGhamdi L, AlKadi M, AlBeajan N, AlRashoudi L, AlHussan M. The burden of diabetes, its oral complications and their prevention and management. Open Access Maced J Med Sci 2018; 6 (08) 1545-1553
  • 3 Rodrigues CF, Rodrigues ME, Henriques M. Candida sp. infections in patients with diabetes mellitus. J Clin Med 2019; 8 (01) 76
  • 4 Dunne MR, Wagener J, Loeffler J, Doherty DG, Rogers TR. Unconventional T cells - new players in antifungal immunity. Clin Immunol 2021; 227: 108734
  • 5 Aitken-Saavedra J, Lund RG, González J. et al. Diversity, frequency and antifungal resistance of Candida species in patients with type 2 diabetes mellitus. Acta Odontol Scand 2018; 76 (08) 580-586
  • 6 Verhulst MJL, Loos BG, Gerdes VEA, Teeuw WJ. Evaluating all potential oral complications of diabetes mellitus. Front Endocrinol (Lausanne) 2019; 10 (02) 56
  • 7 Baitule S, Patel AH, Murthy N. et al. A systematic review to assess the impact of hyperbaric oxygen therapy on glycaemia in people with diabetes mellitus. Medicina (Kaunas) 2021; 57 (10) 1134
  • 8 Mulawarmanti D, Parisihni K, Widyastuti W. The impact of hyperbaric oxygen therapy on serum c-reactive protein levels, osteoprotegerin expression, and osteoclast numbers in induced-periodontitis diabetic rats. Eur J Dent 2020; 14 (03) 404-409
  • 9 Pargaputri AF, Andriani D. Pengaruh pemberian terapi oksigen hiperbarik terhadap jumlah limfosit darah pada kandidiasis oral Imunosupresi model. Jurnal Kedokteran Gigi 2018; 12 (02) 117-125
  • 10 Maqbool M, Mir SA. ‘Animal models of diabetes mellitus: an overview’, Nippon rinsho. Jpn J Clin Med 2019; 9 (01) 472-475
  • 11 Srinivasan K, Ramarao P. Animal models in type 2 diabetes research: an overview. Indian J Med Res 2007; 125 (03) 451-472
  • 12 Kohli S, Shinde CV. Candidiasis and oral cavity: a review. Int J Res Rev 2019; 6 (05) 335-340
  • 13 Rai A, Misra SR, Panda S. et al. Nystatin effectiveness in oral candidiasis treatment: a systematic review & meta-analysis of clinical trials. Life (Basel) 2022; 12 (11) 1677
  • 14 Liu Y, Zhang D, Yuan J. et al. Hyperbaric oxygen ameliorates insulin sensitivity by increasing GLUT4 expression in skeletal muscle and stimulating ucp1 in brown adipose tissue in T2DM mice. Front Endocrinol (Lausanne) 2020; 11 (32) 32
  • 15 Wei R, Li P, Xue Y, Liu Y, Gong W, Zhao W. Impact of diabetes mellitus on the immunity of tuberculosis patients: a retrospective, cross-sectional study. Risk Manag Healthc Policy 2022; 15 (01) 611-627
  • 16 Koyasu S, Moro K. Role of innate lymphocytes in infection and inflammation. Front Immunol 2012; 3 (05) 101
  • 17 Khanam A, Hithamani G, Naveen J, Pradeep SR, Barman S, Srinivasan K. Management of invasive infections in diabetes mellitus: a comprehensive review. Biologics 2023; 3: 40-71
  • 18 Ernawati DS, Surboyo MDC, Ayuningtyas NF, Nagoro AAB. Role of inflammatory cell responses in stimulating fibroblasts in diabetic oral ulcer after treatment with liquid smoke of coconut endocarp: a histological assessment. Eur J Dent 2021; 15 (01) 71-76
  • 19 Ortega MA, Fraile-Martinez O, García-Montero C. et al. A General overview on the hyperbaric oxygen therapy: applications, mechanisms and translational opportunities. Medicina (Kaunas) 2021; 57 (09) 864
  • 20 Woo J, Min JH, Lee YH, Roh HT. Effects of hyperbaric oxygen therapy on inflammation, oxidative/antioxidant balance, and muscle damage after acute exercise in normobaric, normoxic and hypobaric, hypoxic environments: a pilot study. Int J Environ Res Public Health 2020; 17 (20) 7377
  • 21 Korpinar S, Uzun H. The effect of hyperbaric oxygen at different pressures on oxidative stress and antioxidant status in rats. Medicina (B Aires) 2019; 55 (02) 1-8
  • 22 Li FQ, Ma CF, Shi LN. et al. Diagnostic value of immunoglobulin G antibodies against Candida enolase and fructose-bisphosphate aldolase for candidemia. BMC Infect Dis 2013; 13: 253
  • 23 Samaranayake YH, Samaranayake LP. Experimental oral candidiasis in animal models. Clin Microbiol Rev 2001; 14 (02) 398-429
  • 24 Laihad FM, Sudiana IK, Guritno MS. Literature review: hyperbaric oxygen therapy on mucormycosis infection in oral cavity. Folia Medica Indonesiana. 2017; 53 (02) 163-168
  • 25 Andriani D, Setyaningtyas D. Nafi’ah. Efek ekstrak acanthus ilicifolius terhadap ekspresi antibodi anticandida albicans pada tikus wistar terimunosupresi oral kandidiasis. Denta Jurnal Kedokteran Gigi 2017; 11 (01) 35-41
  • 26 Segal E, Menhusen MJ, Shawn S. Hyperbaric oxygen in the treatment of invasive fungal infections: a single-center experience. Isr Med Assoc J 2007; 9 (05) 355-357
  • 27 Forsyth CB, Mathews HL. Lymphocyte adhesion to Candida albicans . Infect Immun 2002; 70 (02) 517-527
  • 28 Dhingra S, Buckey JC, Cramer RA. Hyperbaric oxygen reduces Aspergillus fumigatus proliferation in vitro and influences in vivo disease outcomes. Antimicrob Agents Chemother 2018; 62 (03) 17-18